ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Tatva Chintan Pharma Chem (TATVA.NSE)
Tatva Chintan Pharma Chem share price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · National Stock Exchange of India · India
₹1,568▼ -0.11%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Tatva Chintan Pharma Chem in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Tatva Chintan Pharma Chem
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Tatva Chintan Pharma Chem a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,432 and ₹1,700; in 9 out of 10, between ₹1,230 and ₹1,980. Estimated annual volatility is 51%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹44.5B
- Market cap (USD)
- $470M
- P/E ratio
- 61.9
- Dividend yield
- 0.51%
- 52-week high
- ₹2,114
- 52-week low
- ₹1,044
- Revenue (12 months)
- ₹6.5B
- Operating margin
- 13.8%
- Net margin
- 9.7%
- Beta
- 0.30
What this means
ATLAS does not publish a fair value for TATVA.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks TATVA.NSE has traded between ₹1,044 and ₹2,114. Today it is 25.8% below that high and 50% above its low.
On the business: net margin is 9.7%; it trades at 61.9 times earnings.
Its beta is 0.30: it tends to move less than the market.
About the company
Tatva Chintan Pharma Chem Limited is a leading chemical manufacturing company involved in the production of specialty chemicals and pharmaceuticals.
Want to see everything about Tatva Chintan Pharma Chem?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Tatva Chintan Pharma Chem do?
Tatva Chintan Pharma Chem Limited is a leading chemical manufacturing company involved in the production of specialty chemicals and pharmaceuticals.
What is the chance TATVA.NSE goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, TATVA.NSE ends the month between ₹1,432 and ₹1,700.
How big is Tatva Chintan Pharma Chem and what is its P/E ratio?
Tatva Chintan Pharma Chem's market capitalization is ₹44.5B. Its price-to-earnings (P/E) ratio is 61.9: you pay ₹61.9 for each ₹1.00 of yearly earnings.
Does Tatva Chintan Pharma Chem pay a dividend?
Yes. TATVA.NSE's current dividend yield is 0.51% at today's price (₹1,568).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer